文献速递流行病学与生物统计真实世界研究与卫生经济

低风险女性中冠状动脉钙化的患病率及预后意义:一项Meta分析

Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis.
PubMed 文献 · JAMA · 2016-01-01

该Meta分析纳入5个大型人群队列中10年动脉粥样硬化性心血管疾病(ASCVD)风险低于7.5%的6739名女性,评估冠状动脉钙化(CAC)与ASCVD风险的关系。结果显示36.1%存在CAC,CAC>0与ASCVD风险增加相关(多变量校正HR 2.04,95%CI 1.44-2.90),且CAC加入传统危险因素后C统计量从0.73提升至0.77,cNRI为0.20。作者认为需要进一步研究评估这种额外准确性的临床效用和成本效益。

要点

  • 低ASCVD风险女性中约三分之一存在CAC,CAC>0与ASCVD风险增加相关(HR 2.04)。
  • CAC加入传统危险因素后C统计量从0.73升至0.77,cNRI为0.20。
  • 作者认为需进一步研究评估CAC额外准确性的临床效用和成本效益。

核心结论

  • 在低ASCVD风险女性中,CAC存在率约三分之一,与ASCVD风险增加相关,且相比传统危险因素对预后准确性有适度改善。

研究设计与样本

  • 固定效应Meta分析,纳入5个大型人群队列(Dallas心脏研究、Framingham心脏研究、Heinz Nixdorf Recall研究、多民族动脉粥样硬化研究、Rotterdam研究)中10年ASCVD风险低于7.5%的女性,共6739人。

主要发现

  • 6739名低ASCVD风险女性中,平均年龄范围44至63岁,CAC存在率为36.1%。
  • 中位随访范围7.0至11.6年,共发生165例ASCVD事件(64例非致死性心肌梗死、29例冠心病死亡、72例卒中),ASCVD发病率范围1.5至6.0/1000人年。
  • CAC>0与CAC=0相比,ASCVD发病率分别为4.33/1000人年 vs 1.41/1000人年,差值2.92(95%CI 2.02-3.83),多变量校正HR为2.04(95%CI 1.44-2.90)。
  • CAC加入传统危险因素后,C统计量从0.73(95%CI 0.69-0.77)提升至0.77(95%CI 0.74-0.81),cNRI为0.20(95%CI 0.09-0.31)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 进一步研究需要评估这种额外准确性的临床效用和成本效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The role of coronary artery calcium (CAC) testing for guiding preventive strategies among women at low cardiovascular disease (CVD) risk based on the American College of Cardiology and American Heart Association CVD prevention guidelines is unclear. OBJECTIVE: To assess the potential utility of CAC testing for CVD risk estimation and stratification among low-risk women. DESIGN, SETTING, AND PARTICIPANTS: Women with 10-year atherosclerotic CVD (ASCVD) risk lower than 7.5% from 5 large population-based cohorts: the Dallas Heart Study (United States), the Framingham Heart Study (United States), the Heinz Nixdorf Recall study (Germany), the Multi-Ethnic Study of Atherosclerosis (United States), and the Rotterdam Study (the Netherlands). The 5 cohorts were selected based on the availability of CAC data in a sizable group of low-risk women from the general population together with the long detailed follow-up data. Across the cohorts, events were assessed from the date of CAC scan (performed from 1998 through 2006) until January 1, 2012; January 1, 2014; or March 6, 2015. Fixed-effects meta-analysis was conducted to combine the results of the 5 studies. EXPOSURES: CAC score by computed tomography. MAIN OUTCOMES AND MEASURES: Main outcome was incident ASCVD, including nonfatal myocardial infarction, coronary heart disease (CHD) death, and stroke. Association of CAC with ASCVD was examined using Cox proportional hazards models. To assess whether CAC was associated with improved ASCVD risk predictions beyond the traditional risk factors, the C statistic and the continuous net reclassification improvement (cNRI) index were calculated. RESULTS: Among 6739 women with low ASCVD risk from the 5 studies, mean age ranged from 44 to 63 years and CAC was present in 36.1%. Across the cohorts, median follow-up ranged from 7.0 to 11.6 years. A total of 165 ASCVD events occurred (64 nonfatal myocardial infarctions, 29 CHD deaths, and 72 strokes), with the ASCVD incidence rates ranging from 1.5 to 6.0 per 1000 person-years. Compared with the absence of CAC (CAC = 0), presence of CAC (CAC >0) was associated with an increased risk of ASCVD (incidence rates per 1000 person-years, 1.41 for CAC absence vs 4.33 for CAC presence; difference, 2.92 [95% CI, 2.02-3.83]; multivariable-adjusted hazard ratio, 2.04 [95% CI, 1.44-2.90]). The addition of CAC to traditional risk factors improved the C statistic from 0.73 (95% CI, 0.69-0.77) to 0.77 (95% CI, 0.74-0.81) and provided a cNRI of 0.20 (95% CI, 0.09-0.31) for ASCVD prediction. CONCLUSIONS AND RELEVANCE: Among women at low ASCVD risk, CAC was present in approximately one-third and was associated with an increased risk of ASCVD and modest improvement in prognostic accuracy compared with traditional risk factors. Further research is needed to assess the clinical utility and cost-effectiveness of this additional accuracy.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Kavousi M, Desai CS, Ayers C, et al. Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis. JAMA. 2016. PMID: 27846641. doi:10.1001/jama.2016.17020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。